Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Trubion Pharmaceuticals, Inc | v54725e10vk.htm |
| EX-31.2 - EX-31.2 - Trubion Pharmaceuticals, Inc | v54725exv31w2.htm |
| EX-31.1 - EX-31.1 - Trubion Pharmaceuticals, Inc | v54725exv31w1.htm |
| EX-23.1 - EX-23.1 - Trubion Pharmaceuticals, Inc | v54725exv23w1.htm |
| EX-10.30 - EX-10.30 - Trubion Pharmaceuticals, Inc | v54725exv10w30.htm |
Exhibit 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Trubion Pharmaceuticals, Inc. (the “Company”) on Form
10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on
the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such
officer’s knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company as of the dates and for the periods
expressed in the Report.
Date: March 15, 2010
| /s/ Steven Gillis | ||||||
| Name: | Steven Gillis, Ph.D. | |||||
| Title: Executive Chairman and Acting President | ||||||
| /s/ John A. Bencich | ||||||
| Name: | John A. Bencich | |||||
| Title: | Vice President and | |||||
| Chief Financial Officer | ||||||
| (Principal Accounting and Financial Officer) | ||||||